NASDAQ:JYNT Joint (JYNT) Stock Price, News & Analysis $14.30 +0.67 (+4.92%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$13.61▼$14.3050-Day Range$12.66▼$17.2252-Week Range$7.31▼$17.82Volume39,629 shsAverage Volume78,822 shsMarket Capitalization$214.07 millionP/E RatioN/ADividend YieldN/APrice Target$22.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Joint alerts: Email Address Joint MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.50 Rating ScoreUpside/Downside53.8% Upside$22.00 Price TargetShort InterestHealthy3.04% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.70Based on 6 Articles This WeekInsider TradingN/AProj. Earnings Growth215.00%From $0.20 to $0.63 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.76 out of 5 starsMedical Sector244th out of 936 stocksPatent Owners & Lessors Industry2nd out of 7 stocks 3.3 Analyst's Opinion Consensus RatingJoint has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 2 buy ratings, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageJoint has only been the subject of 2 research reports in the past 90 days.Read more about Joint's stock forecast and price target. Previous Next 4.0 Short Interest Percentage of Shares Shorted3.04% of the outstanding shares of Joint have been sold short.Short Interest Ratio / Days to CoverJoint has a short interest ratio ("days to cover") of 7.1.Change versus previous monthShort interest in Joint has recently decreased by 14.79%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldJoint does not currently pay a dividend.Dividend GrowthJoint does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for JYNT. Previous Next 2.6 News and Social Media Coverage News SentimentJoint has a news sentiment score of 0.70. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 6 news articles for Joint this week, compared to 2 articles on an average week.MarketBeat Follows3 people have added Joint to their MarketBeat watchlist in the last 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Joint insiders have not sold or bought any company stock.Percentage Held by Insiders30.20% of the stock of Joint is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions76.88% of the stock of Joint is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Joint's insider trading history. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for Joint are expected to grow by 215.00% in the coming year, from $0.20 to $0.63 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Joint is -19.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Joint is -19.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioJoint has a P/B Ratio of 8.51. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Joint's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad DTIHow a $0.25 cent option contract makes my top traders feelIf you don’t know me, I’ve been in the markets for over 40 years… but recently, I’ve discovered a breakthrough that might be my favorite strategy of ALL time! While I kept the finer details of these $0.25 Cent Trades under wraps until recently…Click now to see for yourself what $0.25 Cent Trades is all about About Joint Stock (NASDAQ:JYNT)The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.Read More JYNT Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart JYNT Stock News HeadlinesJuly 25 at 7:05 AM | globenewswire.comThe Joint Corp. to Host Conference Call on Thursday, August 8th to Discuss Second Quarter 2024 ResultsJuly 25 at 2:48 AM | finance.yahoo.comThe Joint Corp. (NASDAQ:JYNT) has caught the attention of institutional investors who hold a sizeable 48% stakeJuly 26, 2024 | DTI (Ad)We’re in a code red crisis and 99% of Americans are clueless Folks, it's 2024… Things that we used to rely on - are failing us. Take the phasing out of fossil fuels… Matched with the destruction of oil refineries around the world… And the outright failure of solar and wind technologies… But there is just one solution… And right now governments around the world are stockpiling this resource at the fastest rate in DECADES! July 20, 2024 | americanbankingnews.comThe Joint Corp. (NASDAQ:JYNT) Given Average Rating of "Moderate Buy" by AnalystsMay 13, 2024 | globenewswire.comThe Joint Corp. Engages Capstone Partners to Accelerate Refranchising EffortsMay 7, 2024 | globenewswire.comThe Joint Corp. to Participate in Upcoming Investor ConferencesMay 6, 2024 | finance.yahoo.comThe Joint Corp. (NASDAQ:JYNT) Q1 2024 Earnings Call TranscriptMay 4, 2024 | markets.businessinsider.comThe Joint Corp (JYNT): Hold Rating Maintained Amidst Transition and Mixed PerformanceJuly 26, 2024 | DTI (Ad)We’re in a code red crisis and 99% of Americans are clueless Folks, it's 2024… Things that we used to rely on - are failing us. Take the phasing out of fossil fuels… Matched with the destruction of oil refineries around the world… And the outright failure of solar and wind technologies… But there is just one solution… And right now governments around the world are stockpiling this resource at the fastest rate in DECADES! May 4, 2024 | finance.yahoo.comJoint First Quarter 2024 Earnings: EPS Beats ExpectationsMay 4, 2024 | finance.yahoo.comIs The Joint Corp. (NASDAQ:JYNT) Trading At A 48% Discount?May 4, 2024 | cnet.comBest Banks for Joint Accounts for May 2024May 3, 2024 | markets.businessinsider.comLake Street Keeps Their Buy Rating on Joint (JYNT)May 3, 2024 | finance.yahoo.comThe Joint Corp (JYNT) Q1 2024 Earnings: Revenue Grows, Surpassing Analyst ProjectionsMay 2, 2024 | investorplace.comJYNT Stock Earnings: Joint Beats EPS, Beats Revenue for Q1 2024May 2, 2024 | globenewswire.comThe Joint Corp. Reports First Quarter 2024 Financial ResultsMay 1, 2024 | msn.comJoint Q1 2024 Earnings PreviewMay 1, 2024 | markets.businessinsider.comThe Joint earnings: here's what to expectSee More Headlines Receive JYNT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Joint and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/02/2024Today7/26/2024Next Earnings (Confirmed)8/08/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Patent owners & lessors Sub-IndustryTrading Current SymbolNASDAQ:JYNT CUSIPN/A CIK1612630 Webwww.thejoint.com Phone(480) 245-5960Fax480-513-7989Employees320Year FoundedN/APrice Target and Rating Average Stock Price Target$22.00 High Stock Price Target$30.00 Low Stock Price Target$16.00 Potential Upside/Downside+58.7%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)($0.75) Trailing P/E RatioN/A Forward P/E Ratio69.30 P/E GrowthN/ANet Income$-9,750,000.00 Net Margins-9.24% Pretax Margin-0.34% Return on Equity3.94% Return on Assets1.29% Debt Debt-to-Equity RatioN/A Current Ratio1.34 Quick Ratio1.34 Sales & Book Value Annual Sales$117.70 million Price / Sales1.76 Cash Flow$0.74 per share Price / Cash Flow18.85 Book Value$1.68 per share Price / Book8.25Miscellaneous Outstanding Shares14,970,000Free Float10,452,000Market Cap$207.48 million OptionableOptionable Beta1.60 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Key ExecutivesMr. Peter D. Holt (Age 65)CEO, President & Director Comp: $469.55kJake Singleton (Age 42)Chief Financial Officer Comp: $280.92kMr. Jorge ArmenterosSenior Vice President of OperationsMr. Charles NellesChief Technology OfficerDr. Steven KnaufVice President of Chiropractic & ComplianceMs. Lori I. Abou Habib (Age 44)Chief Marketing Officer Ms. Krischelle TennessenChief Human Resources OfficerMr. Eric SimonSenior VP of Franchise Sales & DevelopmentMr. Craig P. Colmar J.D. (Age 71)Secretary Comp: $37kMore ExecutivesKey CompetitorsDigital TurbineNASDAQ:APPSAcacia ResearchNASDAQ:ACTGTPG RE Finance TrustNYSE:TRTXCommunity Healthcare TrustNYSE:CHCTUP FintechNASDAQ:TIGRView All CompetitorsInsiders & InstitutionsSkylands Capital LLCSold 56,325 shares on 7/26/2024Ownership: 4.226%Bank of New York Mellon CorpSold 1,394 shares on 7/26/2024Ownership: 0.326%Avondale Wealth ManagementBought 3,000 shares on 7/12/2024Ownership: 0.147%Boston PartnersSold 13,526 shares on 5/28/2024Ownership: 0.103%Janus Henderson Group PLCSold 1,828 shares on 5/16/2024Ownership: 0.293%View All Insider TransactionsView All Institutional Transactions JYNT Stock Analysis - Frequently Asked Questions How have JYNT shares performed this year? Joint's stock was trading at $9.61 at the beginning of 2024. Since then, JYNT stock has increased by 48.8% and is now trading at $14.30. View the best growth stocks for 2024 here. How were Joint's earnings last quarter? The Joint Corp. (NASDAQ:JYNT) posted its quarterly earnings results on Thursday, May, 2nd. The company reported $0.06 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.03) by $0.09. The business earned $29.72 million during the quarter, compared to analyst estimates of $29.17 million. Joint had a negative net margin of 9.24% and a positive trailing twelve-month return on equity of 3.94%. What is Peter D. Holt's approval rating as Joint's CEO? 87 employees have rated Joint Chief Executive Officer Peter D. Holt on Glassdoor.com. Peter D. Holt has an approval rating of 59% among the company's employees. This puts Peter D. Holt in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. When did Joint IPO? Joint (JYNT) raised $20 million in an IPO on Tuesday, November 11th 2014. The company issued 3,000,000 shares at $6.50 per share. Roth Capital Partners and Feltl and Company acted as the underwriters for the IPO and Sanders Morris Harris was co-manager. Who are Joint's major shareholders? Top institutional shareholders of Joint include Skylands Capital LLC (4.23%), Bank of New York Mellon Corp (0.33%) and Avondale Wealth Management (0.15%). Insiders that own company stock include Bandera Partners Llc, Peter D Holt, Jake Singleton, Ronald V Davella and Glenn J Krevlin. View institutional ownership trends. How do I buy shares of Joint? Shares of JYNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Joint own? Based on aggregate information from My MarketBeat watchlists, some other companies that Joint investors own include Advanced Micro Devices (AMD), RTX (RTX), Salesforce (CRM), Mastercard (MA), Starbucks (SBUX) and Twitter (TWTR). This page (NASDAQ:JYNT) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredNEW AI developed by trader who won 1,129% (in 2 days)Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands o...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredWhy is NVDA stumbling?July is historically the best month of the year for U.S. stocks. So why are everyone’s favorite tech stocks...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Joint Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Joint With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.